Why Now Is The Perfect Time To Buy GlaxoSmithKline plc
16th January 2015
Life as a shareholder of GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) has not been particularly rewarding of late. For example, shares in the pharmaceutical major have risen by just 12% in the last five years, which is behind even a disappointing FTSE 100 rise of 18% in the same time period.
However, now could be the start of a much more prosperous period for investors in GlaxoSmithKline, and this could be the right time to buy.
Read more at source article: www.fool.co.uk